Survey: the state of orphan drug commercialization

This survey, which should only take 10 minutes to complete, will evaluate life sciences companies’ commercial activities, priorities and challenges related to orphan drugs. If you help in the commercialization of orphan drugs, please consider completing this survey.

Your participation will help us generate robust and comprehensive insights on industry trends and challenges, which we’ll then summarize and share in a report.